Oramed Pharmaceuticals Inc (ORMP) — Cash Flow Reinvestment Rate
Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow Reinvestment Rate of 45.70x as of June 2024, reinvesting $94.66 Million (capex $17.06 plus investments $94.66 Million) from operating cash flow of $2.07 Million. See how much free cash does Oramed Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oramed Pharmaceuticals Inc Cash Flow Reinvestment Rate (2016–2016)
Historical reinvestment intensity for Oramed Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see Oramed Pharmaceuticals Inc (ORMP) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Oramed Pharmaceuticals Inc (2016–2016)
Year-by-year capital reinvestment analysis for Oramed Pharmaceuticals Inc. See ORMP FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.00x | $9.00K | $4.66 Million | $9.00K | — |